CuraRN

NSG210 Hinkle Ch. 26: Assessment and Management of Patients With Vascular Disorders and Problems of Peripheral Circulation

Source: Hinkle & Cheever, Brunner & Suddarth’s Medical-Surgical Nursing 15e, Chapter 26, pp. 818-862 (textbooks/HINKLE_MS_CH26.pdf, also in textbooks/exam03/). Week 08 reading (Alterations in Perfusion / PVD lecture, raw/nsg210_PeripheralVascularDiseases2026.ppt); on Exam 3. Numbering note: the syllabus lists “Ch. 27,” which is hypertension in the 15th edition; the vascular lecture content (PAD, DVT, PE, venous disorders) is in Ch. 26. Detailed PAD lecture notes with slide-vs-textbook differences: nsg210-week-08-peripheral-vascular-diseases-lecture.

Learning Outcomes

  1. Identify anatomic and physiologic factors that affect peripheral blood flow and tissue oxygenation.
  2. Apply assessment parameters for determining the status of peripheral circulation.
  3. Use the nursing process for patients with arterial and venous disorders.
  4. Compare pathophysiology, manifestations, management, and prevention of arterial diseases.
  5. Describe pathophysiology, manifestations, management, and prevention of VTE, venous insufficiency, leg ulcers, and varicose veins.

I. Anatomy and Physiology Review

II. Vascular Assessment

Ankle-brachial index (ABI)

Diagnostic tests

III. Arterial vs Venous Insufficiency (Table 26-1)

Feature Arterial Venous
Pain Claudication to constant rest pain Aching, heavy, cramping
Pulses Diminished or absent Present
Skin Pallor on elevation, dependent rubor, shiny, hairless, cool, thick nails Brown hemosiderin staining in gaiter area, thick skin, stasis dermatitis
Edema Minimal Moderate to severe
Ulcer site Toe tips, web spaces, heel, pressure points Medial malleolus (gaiter area), lateral malleolus, anterior tibia
Ulcer look Deep, round, punched-out, pale or black base Superficial, irregular, beefy red granulation, heavy drainage
Position Legs dependent Legs elevated

IV. Arterial Disorders

A. Atherosclerosis

B. Nursing care of peripheral vascular problems (Chart 26-4)

C. Peripheral artery disease (PAD)

D. Upper extremity arterial disease

E. Aortoiliac disease

F. Aneurysms

G. Acute arterial occlusion (embolism and thrombosis)

H. Raynaud phenomenon and acrocyanosis

I. Buerger disease (lecture slides only - not in this chapter; full notes in nsg210-week-08-peripheral-vascular-diseases-lecture)

V. Venous Disorders

A. Venous thromboembolism (VTE): DVT and PE

B. Deep vein thrombosis (DVT)

C. Anticoagulant and thrombolytic agents (Table 26-2)

Drug Type Monitoring / nursing Reversal
Heparin (unfractionated) Binds antithrombin; inactivates IIa, Xa, others; half-life 60-90 minutes IV weight-based on infusion pump or subcut; aPTT 1.5-2 times control (slides: 1.5 times control); platelets for HIT Protamine sulfate (watch hypotension, bradycardia)
Enoxaparin, dalteparin (LMWH) Inhibit Xa Subcut once or twice daily; fewer bleeds, lower HIT risk; can self-administer; OK in pregnancy if indicated Protamine (less effective)
Warfarin Vitamin K antagonist (II, VII, IX, X; proteins C and S) Anticoagulant effect 12-24 hours, antithrombotic 2-7 days; overlap with heparin at start; PT 1.5-2 times normal, INR 2.0-3.0; same time daily; food and drug interactions; CONTRAINDICATED in pregnancy; bridge for procedures Vitamin K, fresh-frozen plasma, prothrombin complex concentrate
Fondaparinux Selective Xa inhibitor Subcut daily; ortho surgery prophylaxis and treatment; caution renal; no routine coag tests -
Rivaroxaban, apixaban, edoxaban Oral direct Xa inhibitors (DOACs) Fixed doses; check renal function; no routine labs; no food or alcohol interactions Andexanet alfa, activated charcoal
Betrixaban Oral Xa inhibitor Prophylaxis in medically ill No antidote
Argatroban IV direct thrombin inhibitor HIT; aPTT and ACT; check liver -
Dabigatran Oral direct thrombin inhibitor Twice daily; renal function Idarucizumab
Alteplase, reteplase, tenecteplase, urokinase Thrombolytics (plasminogen to plasmin) Lyse existing clot; CBC, platelets, aPTT before and after; contraindicated with active bleeding -

D. DVT nursing management

E. Pulmonary embolism (PE)

F. Chronic venous insufficiency / postthrombotic syndrome

G. Compression therapy

H. Leg ulcers

I. Varicose veins

VI. Lymphatic Disorders and Cellulitis

Lecture vs Textbook Differences

From the Week 08 PVD deck (nsg210-week-08-peripheral-vascular-diseases-lecture); full Exam 3 list in nsg210-exam-3-lecture-vs-textbook.

Item Lecture slides Textbook (this chapter)
ABI normal 1.0 1.00-1.40; over 1.40 noncompressible
ABI claudication 0.95-0.50 0.50-0.90
ABI severe ischemia Under 0.25 Under 0.40
ABI ankle cuff Calf Above malleolus
Claudication occlusion 50-70% About 50% diameter / 75% area
MRA No contrast IV contrast
Heparin aPTT 1.5 times control 1.5-2 times control
IPC pressure 35-55 mm Hg 30-70 mm Hg

High-Yield Numbers

Priority Nursing Actions and Red Flags